Cardiovascular Toxicology

Scope & Guideline

Transforming toxicological knowledge into cardiovascular solutions.

Introduction

Welcome to the Cardiovascular Toxicology information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Cardiovascular Toxicology, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1530-7905
PublisherHUMANA PRESS INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2001 to 2024
AbbreviationCARDIOVASC TOXICOL / Cardiovasc. Toxicol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512

Aims and Scopes

The journal 'Cardiovascular Toxicology' primarily focuses on the intersection of cardiovascular health and toxicological research. It aims to publish innovative studies that explore the mechanisms, effects, and therapeutic interventions related to cardiotoxicity caused by various environmental factors, drugs, and diseases. The research methodologies employed include experimental studies, systematic reviews, and clinical investigations.
  1. Cardiotoxicity Mechanisms:
    Research investigating the molecular and cellular mechanisms underlying cardiotoxicity, particularly those induced by chemotherapeutic agents, environmental toxins, and other pharmacological agents.
  2. Therapeutic Interventions:
    Studies focusing on potential protective strategies and therapeutic approaches to mitigate cardiotoxic effects, including the evaluation of natural compounds, pharmacological agents, and lifestyle interventions.
  3. Environmental and Occupational Health:
    Exploration of the impact of environmental pollutants and occupational exposures on cardiovascular health, including studies on heavy metals, particulate matter, and other toxic substances.
  4. Genetic and Epigenetic Factors:
    Research examining the role of genetic predispositions and epigenetic modifications in susceptibility to cardiotoxicity and cardiovascular diseases.
  5. Innovative Diagnostic Tools:
    Development and validation of novel diagnostic methods, including biomarkers and imaging techniques, for early detection and prediction of cardiotoxicity in various patient populations.
The journal has identified several trending and emerging themes that reflect the evolving landscape of cardiovascular toxicology. These areas highlight innovative research directions and increasing relevance to contemporary health challenges.
  1. Nanoparticle Toxicology:
    Research into the cardiotoxic effects of nanoparticles and their protective strategies is gaining momentum, driven by the increasing use of nanotechnology in medicine and environmental applications.
  2. Role of Circular RNAs and Non-coding RNAs:
    Emerging studies are focusing on the role of circular RNAs and other non-coding RNAs in modulating cardiotoxic responses, indicating a growing interest in the regulatory mechanisms of gene expression in cardiovascular health.
  3. Impact of Lifestyle Factors:
    There is an increasing focus on how lifestyle interventions, such as diet, exercise, and fasting, can mitigate cardiotoxicity, reflecting a holistic approach to cardiovascular health.
  4. Integrative Approaches to Cardiotoxicity:
    The integration of multi-omics technologies (genomics, proteomics, metabolomics) to study cardiotoxicity is trending, allowing for a comprehensive understanding of interactions at various biological levels.
  5. Machine Learning in Predicting Cardiotoxicity:
    The application of machine learning algorithms to predict cardiotoxic outcomes is an emerging theme, showing the journal's commitment to incorporating advanced computational methods in cardiovascular research.

Declining or Waning

In contrast to its expanding focus areas, the journal has seen a decline in certain themes that were previously prevalent in its publications. These waning scopes reflect shifts in research priorities and emerging trends in cardiovascular toxicology.
  1. Traditional Cardiovascular Pharmacology:
    Research on classic cardiovascular drugs and their toxicological profiles has decreased, possibly due to a shift towards more contemporary therapeutic agents and innovative drug classes.
  2. Animal Models of Cardiotoxicity:
    While still relevant, studies exclusively using traditional animal models for cardiotoxicity assessment appear to be declining, as researchers increasingly adopt advanced in vitro techniques and humanized models.
  3. Generalized Toxicology Studies:
    Broad toxicological assessments that do not specifically address cardiovascular implications are less frequently published, indicating a more focused approach on cardiovascular-specific toxicological research.
  4. Epidemiological Studies Without Mechanistic Insight:
    Epidemiological research that lacks a mechanistic understanding of cardiovascular toxicity is becoming less common, as the field emphasizes studies that elucidate underlying biological processes.

Similar Journals

VASCULAR PHARMACOLOGY

Connecting research and practice in vascular medicine.
Publisher: ELSEVIER SCIENCE INCISSN: 1537-1891Frequency: 12 issues/year

Vascular Pharmacology, published by Elsevier Science Inc, is a leading journal in the fields of pharmacology and molecular medicine, dedicated to advancing our understanding of vascular biology and therapeutic interventions. With an impressive impact factor reflecting its significant contribution to the scientific community, this journal seeks to publish ground-breaking research that elucidates the molecular mechanisms underlying vascular function and disease, as well as the pharmacological impact of new therapeutic agents. The journal operates under a dual access model, allowing for both subscription and open access options, ensuring that vital research is accessible to a wide audience. As of 2023, it holds a prestigious position in the Q1 category for pharmacology and ranks well in molecular medicine and physiology, reflecting its high quality and relevance. Whether you are a researcher, clinician, or student, Vascular Pharmacology serves as an essential resource to stay at the forefront of cardiovascular pharmacotherapy and vascular biology.

TOXICOLOGY AND INDUSTRIAL HEALTH

Pioneering research at the intersection of health and industry.
Publisher: SAGE PUBLICATIONS INCISSN: 0748-2337Frequency: 12 issues/year

TOXICOLOGY AND INDUSTRIAL HEALTH, published by SAGE PUBLICATIONS INC, is a premier journal in the field of toxicology, public health, and environmental health, with a significant history dating back to 1985. With its ISSN 0748-2337 and E-ISSN 1477-0393, the journal provides a platform for disseminating groundbreaking research and comprehensive reviews that address the complexities of toxic substances in industrial and occupational settings. Despite its Q3 ranking among peers in health, toxicology, and public health, this journal is becoming increasingly influential, reflected in its growing citation metrics. Researchers and professionals benefit from its commitment to fostering knowledge in both theoretical and practical contexts, making it an essential resource for those dedicated to advancing understanding in this vital field. The journal's main objectives include promoting research addressing the implications of toxicology on health and safety standards across industries, ensuring accessibility to current studies for a global audience. Overall, TOXICOLOGY AND INDUSTRIAL HEALTH plays a critical role in bridging the gap between research and real-world applications, proving invaluable to students, professionals, and researchers alike in their pursuit of enhancing public health and environmental safety.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

Exploring the Intersection of Health and Toxicology
Publisher: WILEYISSN: 1095-6670Frequency: 12 issues/year

Journal of Biochemical and Molecular Toxicology, published by Wiley, plays a pivotal role in the advancement of knowledge within the fields of biochemistry, toxicology, and molecular biology. Established in 1998, this esteemed journal has garnered a significant reputation, evidenced by its current placement in the Q2 quartile across several categories, including Biochemistry, Health, Toxicology and Mutagenesis, and Medicine. With an ISSN of 1095-6670 and an E-ISSN of 1099-0461, it serves an international audience, offering critical insights and innovative research that shape our understanding of biochemical interactions and toxicological assessments. While it does not operate on an open-access model, the journal ensures rigorous peer review and high-quality publication standards, making it a valuable resource for researchers, professionals, and students dedicated to the exploration of molecular toxicology. The journal's recognized impact within the scientific community is reflected in its competitive rankings among specialized journals, fostering significant contributions to both academic and applied contexts.

TOXICOLOGY MECHANISMS AND METHODS

Unveiling mechanisms, enhancing understanding.
Publisher: TAYLOR & FRANCIS LTDISSN: 1537-6516Frequency: 9 issues/year

TOXICOLOGY MECHANISMS AND METHODS is a distinguished peer-reviewed journal dedicated to the advancement of toxicological research, published by Taylor & Francis Ltd. With its ISSN 1537-6516 and E-ISSN 1537-6524, this esteemed journal features critical studies and innovative methodologies in the field of toxicology, aligning with its mission to enhance understanding of biological mechanisms and risk assessment. The journal holds a commendable Q2 ranking in both the Health, Toxicology and Mutagenesis, and Toxicology categories, as well as strong positions in Scopus rankings, reflecting its influence with a 71st percentile rank in Toxicology and a 69th percentile rank in Environmental Health. Researchers, professionals, and students in the toxicology domain will find this journal to be an invaluable resource, offering open access options that foster widespread dissemination of its findings. Since its inception, encompassing converged years from 1991 to 1995 and from 2002 to 2024, the journal remains at the forefront of critical discourse and innovative research methods, making it a vital platform for advancing toxicological science globally.

INHALATION TOXICOLOGY

Transforming Research into Real-World Solutions.
Publisher: TAYLOR & FRANCIS LTDISSN: 0895-8378Frequency: 14 issues/year

Inhalation Toxicology, published by Taylor & Francis Ltd, is a premier journal dedicated to advancing the field of toxicology with a particular focus on inhalation exposure and its impact on human health. Established in 1989, this journal provides a vital platform for original research, reviews, and case studies that explore the toxicological effects of inhaled substances, making it essential reading for researchers, health professionals, and regulatory scientists. With an Impact Factor that situates it in the Q3 category in both Health, Toxicology and Mutagenesis, the journal asserts its relevance within the scientific community, particularly emphasizing its contributions as indexed by Scopus rankings in related fields. Although it follows a traditional access model, the journal's commitment to delivering high-quality research continues to foster significant discussions and advancements in understanding inhalation toxicology. For those at the forefront of environmental science and pharmacology, Inhalation Toxicology is an indispensable resource for both current research and future innovations in the discipline.

TOXICOLOGICAL SCIENCES

Pioneering Insights in Toxicological Research
Publisher: OXFORD UNIV PRESSISSN: 1096-6080Frequency: 12 issues/year

TOXICOLOGICAL SCIENCES, published by Oxford University Press, is a premier journal in the field of toxicology that has been a cornerstone of scientific discourse since its inception in 1981. With an impressive 2023 impact factor and ranked in the Q1 category for Toxicology, this journal is highly regarded among researchers, professionals, and students dedicated to pharmacology and toxicology. The journal is committed to advancing the understanding of toxicological science, covering a breadth of topics that include the mechanisms of toxicity, risk assessment, and the regulatory aspects affecting public health. With an ISSN of 1096-6080 and an E-ISSN of 1096-0929, TOXICOLOGICAL SCIENCES facilitates open access scholarly work, ensuring that critical research reaches a global audience and promotes collaborative learning. As it converges towards 2024, the journal remains pivotal in shaping the future of toxicology research, providing insights that are essential for developing safer chemicals and protecting environmental health.

Current Vascular Pharmacology

Pioneering Insights in Pharmacology and Cardiology
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1570-1611Frequency: 6 issues/year

Current Vascular Pharmacology is a premier academic journal published by Bentham Science Publications Ltd, focusing on the intersection of pharmacology and cardiovascular medicine. With an impact factor that reflects its significance in the field, this journal ranks in the Q1 category for both Pharmacology and Cardiology, showcasing its dedication to high-quality research. Its Scopus ranks place it in the top percentile of its categories, highlighting its influence among scholars and practitioners alike. Issued since 2003 and continuing through 2024, Current Vascular Pharmacology aims to disseminate cutting-edge findings and foster knowledge exchange among researchers, professionals, and students engaged in cardiovascular pharmacology. Despite being a subscription-based journal, it remains a vital resource for those seeking the latest advancements in drug development and therapeutic interventions for vascular diseases. Located in the United Arab Emirates, the journal serves as an essential platform for global discourse on vascular health.

TOXICOLOGY AND APPLIED PHARMACOLOGY

Elevating Understanding in Toxicology and Applied Pharmacology
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0041-008XFrequency: 24 issues/year

TOXICOLOGY AND APPLIED PHARMACOLOGY, published by Academic Press, Inc. Elsevier Science, stands as a leading journal in the domains of toxicology and pharmacology, with its establishment dating back to 1959. With an impact factor reflecting its academic rigor and relevance, this journal is classified in the Q2 quartile for both pharmacology and toxicology categories, underscoring its significance in the scientific community. It ranks #34 out of 133 in Toxicology and #95 out of 313 in Pharmacology according to Scopus, placing it within the 74th and 69th percentiles, respectively. The journal aims to disseminate quality research that drives advancements in understanding the interactions of drugs and toxic substances within biological systems. Researchers and professionals are invited to contribute and engage with a broad spectrum of articles that cover mechanistic studies, risk assessment, and innovative therapeutic strategies. Although the journal does not offer open access, it continues to be a crucial resource for those who seek to navigate the complex interface of drugs and their toxicological implications.

ARCHIVES OF TOXICOLOGY

Elevating Standards in Toxicological Research
Publisher: SPRINGER HEIDELBERGISSN: 0340-5761Frequency: 12 issues/year

ARCHIVES OF TOXICOLOGY is a prestigious journal published by Springer Heidelberg, dedicated to advancing research in the field of toxicology and related disciplines. With a distinguished history dating back to 1930, this journal has continuously provided vital insights and groundbreaking studies, making it a cornerstone in the areas of health, toxicology, and medicine. Recognized for its high impact, it occupies a top-ranking position in Scopus, with remarkable quartile placements in 2023, categorizing it as Q1 in Health, Toxicology and Mutagenesis, and Q1 in Medicine (Miscellaneous). The journal highlights critical research and innovative methodologies, appealing to a diverse audience of researchers, professionals, and students committed to understanding the complexities of toxic substances and their implications for public health and environmental safety. The journal does not currently offer open access, allowing for a more traditional but rigorous peer-review process that ensures the quality and integrity of every published article. Join the global discourse in toxicological science with ARCHIVES OF TOXICOLOGY, where every contribution furthers the understanding of safety and toxicity in our world.

JOURNAL OF TOXICOLOGICAL SCIENCES

Enhancing Knowledge in Toxicology and Beyond
Publisher: JAPANESE SOC TOXICOLOGICAL SCIENCESISSN: 0388-1350Frequency: 4 issues/year

The Journal of Toxicological Sciences, published by the Japanese Society of Toxicological Sciences, is a prominent academic journal dedicated to the comprehensive study of toxicology and its related fields. Since its inception in 1976, the journal has provided a vital platform for researchers and professionals to disseminate innovative findings and insights in toxicology, with a focus on both experimental and clinical studies. Positioned in the Q3 quartile across various relevant categories, including Medicine (miscellaneous) and Toxicology as of 2023, the journal plays an essential role in advancing our understanding of toxic substances and their effects on biological systems. Although currently not open access, the journal maintains high academic standards and is indexed in Scopus, ranking #96 in Toxicology. Offering unique perspectives from Japan, it encourages global collaboration and discourse among toxicologists, making it an invaluable resource for students, researchers, and industry professionals alike.